Literature DB >> 17595302

Probiotics for Clostridium difficile diarrhea: putting it into perspective.

Kelly Dowhower Karpa.   

Abstract

Clostridium difficile diarrhea is an expensive, life-threatening infection associated with serious morbidity and mortality, even among previously healthy individuals. Relapses from the infection are common following standard antibiotic treatments, with 3-5% of patients who contract C. difficile diarrhea unable to discontinue vancomycin due to continual relapses. Such patients may have a focal immunodeficiency in which they fail to mount an immune response against C. difficile. For these individuals, antimicrobial therapies are unable to eradicate the microorganism because no antibiotics are capable of killing C. difficile spores. Although they are considered alternative medicine, probiotics have provided a safe and effective means of restoring gastrointestinal flora and alleviating diarrhea, particularly for individuals experiencing multiple relapses.

Entities:  

Mesh:

Year:  2007        PMID: 17595302     DOI: 10.1345/aph.1K228

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  6 in total

1.  Are probiotics safe for use during pregnancy and lactation?

Authors:  Jackie Elias; Pina Bozzo; Adrienne Einarson
Journal:  Can Fam Physician       Date:  2011-03       Impact factor: 3.275

2.  Inhibition of Clostridium difficile in Mice Using a Mixture of Potential Probiotic Strains Enterococcus faecalis NM815, E. faecalis NM915, and E. faecium NM1015: Novel Candidates to Control C. difficile Infection (CDI).

Authors:  Nahla M Mansour; Walid F Elkhatib; Khaled M Aboshanab; May M A Bahr
Journal:  Probiotics Antimicrob Proteins       Date:  2018-09       Impact factor: 4.609

Review 3.  The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts.

Authors:  Sylvia Cruchet; Raquel Furnes; Aldo Maruy; Eduardo Hebel; Jorge Palacios; Fernando Medina; Nelson Ramirez; Marina Orsi; Lysette Rondon; Vera Sdepanian; Luis Xóchihua; Manuel Ybarra; Roberto Arturo Zablah
Journal:  Paediatr Drugs       Date:  2015-06       Impact factor: 3.022

4.  Side Effects Associated with Probiotic Use in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Maria Pina Dore; Stefano Bibbò; Gianni Fresi; Gabrio Bassotti; Giovanni Mario Pes
Journal:  Nutrients       Date:  2019-12-02       Impact factor: 5.717

5.  New advances in the treatment of Clostridium difficile infection (CDI).

Authors:  Dennis D Hedge; Joe D Strain; Jodi R Heins; Debra K Farver
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

Review 6.  Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system.

Authors:  Heike Stier; Stephan C Bischoff
Journal:  Clin Exp Gastroenterol       Date:  2016-09-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.